XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net loss $ (71,819) $ (69,236) $ (61,256)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 24,503 21,460 15,303
Share-based compensation expense 156,657 131,106 95,171
Non-cash operating lease expense 8,974 8,389 8,457
Net amortization of premium or discount on investments (5,240) (6,566) (6,405)
Losses (gains) on foreign exchange (819) 642 (421)
Changes in operating assets and liabilities, net of effects of business combinations:      
Accounts receivable (29,328) (13,512) (14,109)
Prepaid expenses and other assets (5,491) (7,821) 2,162
Deferred contract acquisition costs (15,069) (12,084) (7,807)
Accounts payable 3,618 (7,317) 1,705
Accrued expenses and other liabilities 20,775 13,839 10,681
Operating lease liabilities (8,789) (8,107) (7,716)
Deferred revenue 67,757 60,131 38,390
Net cash provided by operating activities 145,729 110,924 74,155
Cash flows from investing activities:      
Purchases of short-term investments (625,867) (513,591) (392,406)
Maturities of short-term investments 477,059 409,914 336,883
Sales of short-term investments 0 98,178 4,029
Purchases of property and equipment (3,460) (3,143) (1,982)
Payments for business combinations, net of cash acquired 0 (156,714) 0
Net cash used in investing activities (152,268) (165,356) (53,476)
Cash flows from financing activities:      
Proceeds from exercise of share options 12,055 10,352 9,985
Proceeds from employee share purchase plan 11,917 8,744 6,665
Proceeds from employee equity transactions, net of payments to tax authorities and employees 7,238 2,135 1,721
Net cash provided by financing activities 31,210 21,231 18,371
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1,253 (949) 120
Net increase (decrease) in cash, cash equivalents, and restricted cash 25,924 (34,150) 39,170
Cash, cash equivalents, and restricted cash—beginning of period 50,627 84,777 45,607
Cash, cash equivalents, and restricted cash—end of period 76,551 50,627 84,777
Supplemental disclosure of noncash investing and financing activities:      
Purchase of property and equipment during the period included in accounts payable 53 60 187
Fair value of ordinary shares issued as consideration for business combination 0 13,420 0
Fair value of replacement awards in business combination $ 0 $ 375 $ 0